Furthermore, the association between SV40 and germinal center biology, as well as p53 and BCL2 expression, was evaluated in SV40-positive (n = 48) and -negative (n = 38) DLBCL patients (n = 86). Here, BCL2 is linked to diffuse large B-cell lymphoma.